CN103223156B - Traditional Chinese medicine composition used for treating eczema - Google Patents
Traditional Chinese medicine composition used for treating eczema Download PDFInfo
- Publication number
- CN103223156B CN103223156B CN201310186962.6A CN201310186962A CN103223156B CN 103223156 B CN103223156 B CN 103223156B CN 201310186962 A CN201310186962 A CN 201310186962A CN 103223156 B CN103223156 B CN 103223156B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- radix
- eczema
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a traditional Chinese medicine composition used for treating eczema. The traditional Chinese medicine composition is prepared from rhizoma smilacis glabrae, acanthopanax, milkvetch, schisandra chinensis, rhodiola rosea, red peony root, sea-buckthorn and ginger, in certain parts by weight. The traditional Chinese medicine composition can be prepared into a medicine used for treating the eczema and has the advantages of obvious curative effect, no side effect and high safety.
Description
Technical field
The present invention relates to Chinese medicine composition field, be specifically related to a kind of Chinese medicine composition that is used for the treatment of eczema.
Background technology
Eczema (eczema) is that caused by the inside and outside factor of Various Complex a kind of has pleomorphism skin lesion and easily have the scytitis that oozes out tendency to react.Primary disease cause of disease complexity is difficult to determine more.Subjective symptoms acute pruritus.The state of an illness easily repeatedly, can be delayed for many years and not heal, and patient's chronicity skin pruritus, suffers untold misery.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition for the preparation for the treatment of eczema, said composition can play clearing away heat-damp and promoting diuresis, dispelling wind for relieving itching, nourshing Yin and drynsessmoistening prescription effect.
Above-mentioned purpose of the present invention is achieved by the following technical programs:
Treat a Chinese medicine composition for eczema, by making according to the raw material of mass fraction meter as follows: Rhizoma Smilacis Glabrae 16 ~ 22%, Radix Et Caulis Acanthopanacis Senticosi 10 ~ 20%, the Radix Astragali 20 ~ 25%, Fructus Schisandrae Chinensis 10 ~ 14%, Radix Rhodiolae 5 ~ 8%, Radix Paeoniae Rubra 8 ~ 10%, Fructus Hippophae 5 ~ 6% and Rhizoma Zingiberis Recens 8 ~ 10%.
As a kind of preferred version, above-mentioned Chinese medicine composition is by making according to the raw material of mass fraction meter as follows: Rhizoma Smilacis Glabrae 20%, Radix Et Caulis Acanthopanacis Senticosi 18%, the Radix Astragali 22%, Fructus Schisandrae Chinensis 12%, Radix Rhodiolae 6%, Radix Paeoniae Rubra 7%, Fructus Hippophae 5% and Rhizoma Zingiberis Recens 10%.
Above-mentioned composition, according to proportioning combination drying, is added to 18 times of water gagings, decoct 3 hours, waste, the medicine of a cold nature soup drink-service of drying in the air.
Compared with prior art, the present invention has following beneficial effect:
The dermatosiss such as eczema belong to the disease that heals, easily recurs compared with refractory.The effect for the treatment of by Chinese herbs is not in the past very desirable, and for instant effect, majority is all to smear hormone medicine to alleviate in affected part, but the side effect of hormone medicine is very large, and has the defect that relapse rate is higher.Find through experiment, Chinese medicine composition of the present invention can be prepared into the medicine for the treatment of eczema, has evident in efficacyly, has no side effect, and safe, to be difficult for recurrence advantage, is conducive to clearing away heat-damp and promoting diuresis, dispelling wind for relieving itching, nourshing Yin and drynsessmoistening prescription.
Detailed description of the invention
Further explain the present invention below in conjunction with embodiment, but embodiment does not limit in any form to the present invention.
embodiment 1
Rhizoma Smilacis Glabrae 20g, Radix Et Caulis Acanthopanacis Senticosi 18g, Radix Astragali 22g, Fructus Schisandrae Chinensis 12g, Radix Rhodiolae 6g, Radix Paeoniae Rubra 7g, Fructus Hippophae 5g and Rhizoma Zingiberis Recens 10g, add 18 times of water gagings after being dried and decoct 180min, and gained decoction is for subsequent use.
embodiment 2
Look for 100 of patients that suffer from eczema.Take embodiment 1 gained decoction, 2 times on the 1st, one after each meal sooner or later, continuous 7 days.
Take patient's statistical result of embodiment 1 gained decoction in table 1.
Table 1
| Natural law | Effective | Invalid | Obvious effective rate (%) |
| 1 day | 25 | 75 | 25 |
| 3 days | 51 | 49 | 51 |
| 5 days | 87 | 13 | 87 |
| 7 days | 100 | 0 | 100 |
Known by above-mentioned data, Chinese medicine of the present invention is made after decoction, can be in 8 days the healing eczema of highly significant.
embodiment 3
Cure after 1 year, for the eczema patients access state of an illness of embodiment 2, confirm none Patients on Recurrence eczema, as can be seen here, this traditional Chinese medicine composition for treating eczema is difficult for recurrence.
embodiment 4
The decoction administration ICR mice that uses embodiment 1 to make, body weight 20 ~ 25g, male and female half and half, successive administration 30d.
Through prerun, the decoction toxicity that embodiment 1 makes is very low, does not measure LD50, measures therefore mice is carried out to maximum dosage-feeding on the one.Maximum dosage-feeding is 800ml/d, observes none example and be poisoned to death after 30 days, and all healthy survival, proves that the decoction that compositions of the present invention is made can toxic side effect to human body thus.
Claims (2)
1. treat a Chinese medicine composition for eczema, it is characterized in that by making decoction according to the raw material of mass fraction meter as follows: Rhizoma Smilacis Glabrae 16 ~ 22%, Radix Et Caulis Acanthopanacis Senticosi 10 ~ 20%, the Radix Astragali 20 ~ 25%, Fructus Schisandrae Chinensis 10 ~ 14%, Radix Rhodiolae 5 ~ 8%, Radix Paeoniae Rubra 8 ~ 10%, Fructus Hippophae 5 ~ 6% and Rhizoma Zingiberis Recens 8 ~ 10%.
2. the Chinese medicine composition for the treatment of eczema according to claim 1, is characterized in that by making decoction according to the raw material of mass fraction meter as follows: Rhizoma Smilacis Glabrae 20%, Radix Et Caulis Acanthopanacis Senticosi 18%, the Radix Astragali 22%, Fructus Schisandrae Chinensis 12%, Radix Rhodiolae 6%, Radix Paeoniae Rubra 7%, Fructus Hippophae 5% and Rhizoma Zingiberis Recens 10%.
3. described in claim 1 or 2, treat the preparation method of the Chinese medicine composition of eczema, it is characterized in that each compositions, according to proportioning combination drying, adding 18 times of water gagings, decoct 3 hours, waste, dries in the air cool and get final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310186962.6A CN103223156B (en) | 2013-05-20 | 2013-05-20 | Traditional Chinese medicine composition used for treating eczema |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310186962.6A CN103223156B (en) | 2013-05-20 | 2013-05-20 | Traditional Chinese medicine composition used for treating eczema |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103223156A CN103223156A (en) | 2013-07-31 |
| CN103223156B true CN103223156B (en) | 2014-09-03 |
Family
ID=48833952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310186962.6A Expired - Fee Related CN103223156B (en) | 2013-05-20 | 2013-05-20 | Traditional Chinese medicine composition used for treating eczema |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103223156B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115006466B (en) * | 2022-07-28 | 2023-05-05 | 四川天福精细化工有限公司 | Traditional Chinese medicine preparation for treating eczema with damp-heat and yang deficiency and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102078455A (en) * | 2010-12-24 | 2011-06-01 | 牛曌 | Saffron liquid |
| CN102579789B (en) * | 2012-03-23 | 2013-05-29 | 李明霞 | Medicine for treating eczema |
-
2013
- 2013-05-20 CN CN201310186962.6A patent/CN103223156B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103223156A (en) | 2013-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102343077A (en) | Traditional Chinese drug formulation for treating bronchitis | |
| CN103223156B (en) | Traditional Chinese medicine composition used for treating eczema | |
| CN103223124B (en) | Traditional Chinese medicine composition used for treating lobar pneumonia | |
| CN101869638A (en) | Traditional Chinese medicine for treating cancer and preparation method thereof | |
| CN103768169A (en) | Traditional Chinese medicine effective part composition for treating erythema nodosum | |
| CN103432237B (en) | Composition consisting of effective traditional Chinese medicine parts and used for treating hypercortisolism | |
| CN104888101A (en) | Traditional Chinese medicine decoction for treating bronchial asthma | |
| CN102600285B (en) | Complex propolis composition for treating infectious atrophic rhinitis of pigs and preparation method thereof | |
| CN103432476B (en) | Composition consisting of effective traditional Chinese medicine parts and used for treating hyperthyroidism | |
| CN103223092B (en) | Traditional Chinese medicine composition used for treating bronchial asthma | |
| CN103223157B (en) | Traditional Chinese medicine composition used for treating cold | |
| CN109106843A (en) | A kind of Chinese medicine proved recipe for treating lung neoplasm | |
| CN103239657B (en) | Chinese medicine composition for treating rheumatoid arthritis | |
| CN103550294B (en) | Traditional Chinese medicine effective part composition for treating urticaria | |
| CN103463534A (en) | Constipation treatment traditional Chinese medicine effective fraction composition | |
| CN103550592A (en) | Traditional Chinese medicinal effective part composition for treating priapism | |
| CN104001031A (en) | Medicament for treating asthma | |
| CN103211952B (en) | Traditional Chinese medicine composition used for treating edema | |
| CN104083601A (en) | Traditional Chinese medicinal preparation for treating diabetes mellitus | |
| CN103585534A (en) | Traditional Chinese medicine effective part composition for treating erythema multiforme | |
| CN103585428A (en) | Traditional Chinese medicine preparation for treating diabetes | |
| CN103550295A (en) | Traditional Chinese medicine effective part composition for treating acne | |
| CN103239685B (en) | Chinese medicine composition for treating psoriasis | |
| CN103432301B (en) | Traditional Chinese medicine effective part composition for treating primary adrenocortical insufficiency | |
| CN102078387A (en) | Traditional Chinese medicine for treating fibroid and ovarian cyst |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140903 Termination date: 20150520 |
|
| EXPY | Termination of patent right or utility model |